Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
Β 

29 October 2018

Β 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of Β£0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

Β£0.05

2,267,084*

Simon Wassall

930,215

Β£0.05

1,259,331

Mark Garratt

381,229

Β£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.Β 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

Β 

b)

Initial notification/amendment

Initial notification

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of Β£0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

Β£0.05

1,385,499

Β£69,274.95

Β 

Β 

Β 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

Β 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

Β 

b)

Initial notification/amendment

Initial notification

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of Β£0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

Β£0.05

930,215

Β£46,510.75

Β 

Β 

Β 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

Β 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

Β 

b)

Initial notification/amendment

Initial notification

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of Β£0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

Β£0.05

381,229

Β£19,061.45

Β 

Β 

Β 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

Β 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHFEUFMMFASEES
Date   Source Headline
1st Nov 20107:00 amRNSTotal Voting Rights
27th Oct 20104:47 pmRNSDirector/PDMR Shareholding
7th Oct 201011:04 amRNSHolding(s) in Company
1st Oct 20107:00 amRNSTotal Voting Rights
30th Sep 201011:32 amRNSIan Davies to join the Board
30th Sep 20107:00 amRNSInterim Results
27th Sep 20104:52 pmRNSDirector/PDMR Shareholding
27th Sep 201012:52 pmRNSHolding(s) in Company
23rd Sep 20109:41 amRNSTransfer of Shares
1st Sep 20107:00 amRNSTotal Voting Rights
27th Aug 20104:36 pmRNSDirector/PDMR Shareholding
11th Aug 201010:27 amRNSHarvey Nash invests in additional City location
11th Aug 20107:00 amRNSTrading update
3rd Aug 201010:34 amRNSNotice of Trading Update
30th Jul 20106:00 pmRNSTotal Voting Rights
28th Jul 20105:18 pmRNSDirector/PDMR Shareholding
5th Jul 20104:29 pmRNSDirector/PDMR Shareholding
1st Jul 20107:00 amRNSTotal Voting Rights
24th Jun 201011:23 amRNSResult of AGM
16th Jun 20107:00 amRNSInterim Management Statement
11th Jun 20106:00 pmRNSBlocklisting Interim Review
1st Jun 20101:22 pmRNSDirector/PDMR Shareholding
1st Jun 20107:00 amRNSTotal Voting Rights
28th May 20109:34 amRNSAnnual Information Update
27th May 20104:12 pmRNSNotice of Annual General Meeting and Annual Report
30th Apr 20103:32 pmRNSDirector/PDMR Shareholding
30th Apr 20107:57 amRNSHarvey Nash wins Alcatel-Lucent contract
30th Apr 20107:00 amRNSPreliminary Full Year Results
30th Apr 20107:00 amRNSTotal Voting Rights
29th Apr 20105:09 pmRNSAcquisition
28th Apr 20104:55 pmRNSTransfer of Shares
27th Apr 201010:29 amRNSHolding(s) in Company
16th Apr 20103:36 pmRNSHolding(s) in Company
1st Apr 20107:00 amRNSTotal Voting Rights
30th Mar 20103:43 pmRNSDirector/PDMR Shareholding
25th Mar 20102:42 pmRNSTransfer of Shares
10th Mar 20102:05 pmRNSHolding(s) in Company
5th Mar 20104:52 pmRNSDirector/PDMR Shareholding
1st Mar 20107:00 amRNSTotal Voting Rights
26th Feb 20107:00 amRNSPre-close Trading Update
1st Feb 201010:34 amRNSTotal Voting Rights
27th Jan 20106:21 pmRNSDirector/PDMR Shareholding
15th Jan 201010:04 amRNSHolding(s) in Company
12th Jan 20104:06 pmRNSHolding(s) in Company
11th Jan 20105:14 pmRNSHolding(s) in Company
11th Jan 20105:14 pmRNSHolding(s) in Company
11th Jan 20105:07 pmRNSTotal Voting Rights
5th Jan 20109:45 amRNSDirector/PDMR Shareholding
4th Jan 201011:26 amRNSDirector/PDMR Shareholding
11th Dec 20097:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.